Revenue (TTM) Chart

View Revenue (TTM) for HIMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
March 31, 2026 2.370B
December 31, 2025 2.348B
September 30, 2025 2.211B
June 30, 2025 2.014B
March 31, 2025 1.784B
December 31, 2024 1.477B
September 30, 2024 1.242B
June 30, 2024 1.067B
March 31, 2024 959.40M
December 31, 2023 872.00M
September 30, 2023 792.58M
June 30, 2023 710.72M
March 31, 2023 616.37M
Date Value
December 31, 2022 526.92M
September 30, 2022 444.41M
June 30, 2022 373.75M
March 31, 2022 320.88M
December 31, 2021 271.88M
September 30, 2021 228.64M
June 30, 2021 195.80M
March 31, 2021 171.01M
December 31, 2020 148.76M
September 30, 2020 107.29M
June 30, 2020 65.97M
March 31, 2020 30.06M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
HealthEquity, Inc. 1.337B
Doximity, Inc. 644.86M
GoodRx Holdings, Inc. 787.89M
Eli Lilly & Co. 72.25B
Ontrak, Inc. 10.18M